Company profile for Shanghai Miracogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shanghai Miracogen Inc., founded in 2014 and headquartered in Shanghai, specializes in developing innovative antibody?drug conjugates (ADCs) for cancer treatment. Its pipeline includes MRG-003 (anti-EGFR ADC) for colorectal and head & neck cancers, and MRG-002 (anti-HER2 ADC), which has advanced to Ph III for metastatic urothelial carcinoma. Miracogen collaborates with global tech platforms like Synaffix, leveraging GlycoConne...
Shanghai Miracogen Inc., founded in 2014 and headquartered in Shanghai, specializes in developing innovative antibody?drug conjugates (ADCs) for cancer treatment. Its pipeline includes MRG-003 (anti-EGFR ADC) for colorectal and head & neck cancers, and MRG-002 (anti-HER2 ADC), which has advanced to Ph III for metastatic urothelial carcinoma. Miracogen collaborates with global tech platforms like Synaffix, leveraging GlycoConnect and HydraSpace for enhanced ADC stability and efficacy. With a global R&D team and industry veterans, the company is committed to delivering safe, effective, and accessible cancer therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No. 1238 Zhangjiang Rd, Building 3, Suite 4E, Pudong District, Shanghai, 20120...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

SCOPE Summit

SCOPE Summit

Not Confirmed

envelop Contact Supplier

SCOPE Summit

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty